ICYMI: New Drugs Push Pharmaceutical Profits Up

According to an article via SFgate.com, “Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers...

Teva Ready to Divest Operations to Win Regulatory Nod for Mylan Buy

In a press release via PharmaVoice.com, “Generic drugmaker Teva Pharmaceutical Industries Ltd said it could “promptly” divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller rival Mylan NV…Teva plans to work...

GlaxoSmithKline, U.K. Government Reach MenB Vaccination Agreement

The UK government has reached a deal with drug company GlaxoSmith Kline to be the first worldwide to routinely vaccinate babies against Meningitis B.  According to an article via PharmaTimes.com, “As a result Bexsero, the only licensed MenB vaccine, will now be...

Baxter International Spinoff to Headquarter in Bannockburn

“Baxter International said Monday its spinoff pharmaceutical company Baxalta will be located in north suburban Bannockburn, not far from Baxter’s headquarters in Deerfield” according to the Chicago Tribune.  Baxalta will produce treatments for...